Shertech’s own Cindi Luckett-Gilbert wins National Award

Congratulations to Shertech’s Cindi Luckett-Gilbert for receiving the first ever Society of Nuclear Medicine Molecular Imaging’s Advocate of the Year Award. She was given this award for outstanding advocacy efforts at the Local, State and National levels. Congratulations to Shertech’s own Cindi Luckett-Gilbert. Shertech Pharmacy is proud to employee individuals like Cindi who demonstrates Shertech’s philosophy […]

Read More...

Cindi Luckett-Gilbert Wins Advocate of the Year

Congratulations to Shertech’s Cindi Luckett-Gilbert for receiving the first ever Society of Nuclear Medicine Molecular Imaging’s Advocate of the Year Award. She was given this award for outstanding advocacy efforts at the Local, State and National levels. Congratulations to Shertech’s own Cindi Luckett-Gilbert. Shertech Pharmacy is proud to employee individuals like Cindi who demonstrates Shertech’s philosophy […]

Read More...

UPPI LLC (United Pharmacy Partners) Proudly Announces That Thirty-One (31) Nuclear Pharmacy Members & Affiliates Received a Recognition Award from the U.S. Department of Energy

SUWANEE, Ga.–(BUSINESS WIRE)–UPPI LLC (United Pharmacy Partners) is proud to announce that thirty-one (31) nuclear pharmacy members and affiliates have received a Recognition Award from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) from Assistant Deputy Administrator Peter H. Hanlon in recognition of providing radiopharmaceuticals of molybdenum 99/technetium 99m derived from sources with […]

Read More...

Nuclear Medicine Radiation Safety in Adult Medical Imaging

The 2009 National Council on Radiation Protection and Measurements, Report No. 160 — Ionizing Radiation Exposure of the Population of the United States — showed that medical exposure to patients is one of the largest sources of radiation exposure to Americans, nearly equaling the exposure from background sources. Nuclear medicine is the second largest source […]

Read More...

FDA approves new diagnostic imaging agent to detect rare neuroendocrine tumors

The U.S. Food and Drug Administration today approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography (PET) imaging. This radioactive probe will help locate tumors in adult and pediatric patients with the rare condition, somatostatin receptor positive neuroendocrine tumors (NETs). NETs are […]

Read More...